CD34 and epilepsy: For example, Giulioni et al. exclusively observed the CD34 expression in low-grade epilepsy-associated tumors (n = 187), and found 54.1% of CD34 positive in GNT, with a higher expression of CD34 in GG than DNT (74.7% vs. 23.5%)3.